US Stock MarketDetailed Quotes

DRMA Dermata Therapeutics

Watchlist
  • 0.3360
  • -0.0041-1.21%
Close May 3 16:00 ET
  • 0.3418
  • +0.0058+1.73%
Post 19:40 ET
2.24MMarket Cap-125P/E (TTM)

Dermata Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
27.45%-6.41M
37.15%-1.15M
30.83%-1.77M
-0.05%-1.84M
36.74%-1.65M
-55.17%-8.83M
-1.20%-1.83M
-15.89%-2.56M
-103.66%-1.84M
-235.97%-2.61M
Net income from continuing operations
18.90%-7.79M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.7M
19.60%-2.24M
-21.62%-9.61M
34.60%-1.67M
-41.55%-2.42M
-105.03%-2.73M
-20.88%-2.79M
Change In working capital
662.38%863.68K
327.75%858.2K
50.60%-183.59K
-142.92%-270.18K
1,428.23%459.25K
-153.04%-153.58K
-244.80%-376.82K
41.92%-371.67K
100.15%629.49K
-109.75%-34.58K
-Change in prepaid assets
33.42%162.7K
-26.10%151.4K
18.05%-417.55K
-44.12%254K
726.18%174.85K
116.26%121.94K
-20.38%204.87K
-36.68%-509.52K
216.87%454.51K
88.64%-27.92K
-Change in payables and accrued expense
354.43%700.98K
221.51%706.8K
69.71%233.96K
-399.58%-524.17K
4,374.78%284.4K
-126.50%-275.52K
-20,034.51%-581.69K
151.60%137.85K
-75.13%174.97K
-101.11%-6.65K
Cash from discontinued investing activities
Operating cash flow
27.45%-6.41M
37.15%-1.15M
30.83%-1.77M
-0.05%-1.84M
36.74%-1.65M
-55.17%-8.83M
-1.20%-1.83M
-15.89%-2.56M
-103.66%-1.84M
-235.97%-2.61M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
77.84%7.61M
1.95M
-17,809.50%-35.42K
-64.64%1.51M
4.18M
-73.21%4.28M
0
-100.00%200
4.28M
0
Net common stock issuance
77.85%7.61M
--1.95M
---35.42K
-64.64%1.51M
--4.17M
-72.21%4.28M
--0
--0
--4.28M
--0
Net preferred stock issuance
----
----
----
----
---40
----
----
----
----
--0
Proceeds from stock option exercised by employees
-34.84%187
--0
--0
-60.92%34
--153
--287
--0
--200
--87
--0
Cash from discontinued financing activities
Financing cash flow
77.84%7.61M
--1.95M
-17,809.50%-35.42K
-64.64%1.51M
--4.18M
-73.21%4.28M
--0
-100.00%200
--4.28M
--0
Net cash flow
Beginning cash position
-42.20%6.24M
-17.79%6.63M
-20.60%8.44M
7.03%8.77M
-42.20%6.24M
1,935.97%10.8M
-35.99%8.07M
2,387.79%10.63M
515.67%8.19M
1,935.97%10.8M
Current changes in cash
126.26%1.2M
144.19%806.65K
29.44%-1.81M
-113.47%-328.23K
196.84%2.53M
-144.38%-4.56M
-1.16%-1.83M
-121.03%-2.56M
369.81%2.44M
-425.97%-2.61M
End cash Position
19.18%7.44M
19.18%7.44M
-17.79%6.63M
-20.60%8.44M
7.03%8.77M
-42.20%6.24M
-42.20%6.24M
-35.99%8.07M
2,387.79%10.63M
515.67%8.19M
Free cash flow
27.45%-6.41M
37.15%-1.15M
30.83%-1.77M
-0.05%-1.84M
36.74%-1.65M
-55.17%-8.83M
-1.20%-1.83M
-15.89%-2.56M
-103.66%-1.84M
-235.97%-2.61M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 27.45%-6.41M37.15%-1.15M30.83%-1.77M-0.05%-1.84M36.74%-1.65M-55.17%-8.83M-1.20%-1.83M-15.89%-2.56M-103.66%-1.84M-235.97%-2.61M
Net income from continuing operations 18.90%-7.79M-27.81%-2.13M29.09%-1.72M37.69%-1.7M19.60%-2.24M-21.62%-9.61M34.60%-1.67M-41.55%-2.42M-105.03%-2.73M-20.88%-2.79M
Change In working capital 662.38%863.68K327.75%858.2K50.60%-183.59K-142.92%-270.18K1,428.23%459.25K-153.04%-153.58K-244.80%-376.82K41.92%-371.67K100.15%629.49K-109.75%-34.58K
-Change in prepaid assets 33.42%162.7K-26.10%151.4K18.05%-417.55K-44.12%254K726.18%174.85K116.26%121.94K-20.38%204.87K-36.68%-509.52K216.87%454.51K88.64%-27.92K
-Change in payables and accrued expense 354.43%700.98K221.51%706.8K69.71%233.96K-399.58%-524.17K4,374.78%284.4K-126.50%-275.52K-20,034.51%-581.69K151.60%137.85K-75.13%174.97K-101.11%-6.65K
Cash from discontinued investing activities
Operating cash flow 27.45%-6.41M37.15%-1.15M30.83%-1.77M-0.05%-1.84M36.74%-1.65M-55.17%-8.83M-1.20%-1.83M-15.89%-2.56M-103.66%-1.84M-235.97%-2.61M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 77.84%7.61M1.95M-17,809.50%-35.42K-64.64%1.51M4.18M-73.21%4.28M0-100.00%2004.28M0
Net common stock issuance 77.85%7.61M--1.95M---35.42K-64.64%1.51M--4.17M-72.21%4.28M--0--0--4.28M--0
Net preferred stock issuance -------------------40------------------0
Proceeds from stock option exercised by employees -34.84%187--0--0-60.92%34--153--287--0--200--87--0
Cash from discontinued financing activities
Financing cash flow 77.84%7.61M--1.95M-17,809.50%-35.42K-64.64%1.51M--4.18M-73.21%4.28M--0-100.00%200--4.28M--0
Net cash flow
Beginning cash position -42.20%6.24M-17.79%6.63M-20.60%8.44M7.03%8.77M-42.20%6.24M1,935.97%10.8M-35.99%8.07M2,387.79%10.63M515.67%8.19M1,935.97%10.8M
Current changes in cash 126.26%1.2M144.19%806.65K29.44%-1.81M-113.47%-328.23K196.84%2.53M-144.38%-4.56M-1.16%-1.83M-121.03%-2.56M369.81%2.44M-425.97%-2.61M
End cash Position 19.18%7.44M19.18%7.44M-17.79%6.63M-20.60%8.44M7.03%8.77M-42.20%6.24M-42.20%6.24M-35.99%8.07M2,387.79%10.63M515.67%8.19M
Free cash flow 27.45%-6.41M37.15%-1.15M30.83%-1.77M-0.05%-1.84M36.74%-1.65M-55.17%-8.83M-1.20%-1.83M-15.89%-2.56M-103.66%-1.84M-235.97%-2.61M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg